SharonAI Holdings Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 22, 2026, details SharonAI Holdings Inc.'s entry into material definitive agreements for a significant capital raise. The Company is an emerging growth company incorporated in Delaware, with its principal executive offices in New York, NY. The report covers transactions closed or expected to close in late June 2026.
Key Financial Metrics and Capital Structure
The filing outlines two primary financing transactions:
- Equity Offering: The Company sold approximately 6,719,896 shares of Class A Ordinary Common Stock and pre-funded warrants for up to 6,374,823 shares. The purchase price was $68.73 per share and $68.7299 per pre-funded warrant, respectively. Aggregate gross proceeds were approximately $900 million. The transaction closed on June 23, 2026.
- Convertible Notes Offering: The Company issued $700 million aggregate principal amount of 4.75% Convertible Senior Notes due 2032. Interest is payable quarterly. The initial conversion price is approximately $99.66 per share (a 45% premium to the Nasdaq Minimum Price at execution). The notes are senior, unsecured obligations, guaranteed by certain subsidiaries.
The filing does not provide specific revenue, profit, cash flow, or margin figures for the reporting period, as this is a transactional filing rather than a periodic financial report.
Material Changes and Transaction Details
The primary material change is the substantial increase in capital and the alteration of the capital structure through the issuance of new equity and debt instruments.
- Equity Terms: Pre-funded warrants are immediately exercisable at $0.0001 per share. Beneficial ownership limitations initially cap exercise at 9.99% of outstanding Common Stock, increasing to 19.99% after HSR satisfaction and 100% following stockholder approval.
- Debt Terms: The Notes mature on June 15, 2032. They are not redeemable by the Company but may be forced converted by the Company after 18 months if specific trading volume and price thresholds (200% of conversion price) are met. A maximum of approximately 14,005,665 shares may be issued upon conversion based on the maximum conversion rate.
- Use of Proceeds: Net proceeds are designated to support a six-year strategic compute collaboration with NVIDIA, including the deployment of up to 40,000 Grace Blackwell GB300 GPUs for one of Australia's largest AI Factories, alongside broader expansion plans.
Outlook, Risks, and Contingencies
Management commentary is limited to the strategic intent of the capital raise. The filing includes standard forward-looking statement disclaimers regarding the expected closing dates and the success of the NVIDIA collaboration.
Risks and Contingencies:
- Dilution: Significant potential dilution exists from the issuance of shares, pre-funded warrants, and the conversion of notes.
- Events of Default: The Indenture specifies events of default including payment defaults, failure to convert, bankruptcy, and judgments exceeding $7.5 million. Certain defaults allow for automatic acceleration of debt.
- Regulatory and Listing: Full exercise of pre-funded warrants is contingent on stockholder approval for NASDAQ Listing Rule 5635(b) compliance.
Investor Verification Checklist
- Verify the final closing status and settlement of the $700 million Notes Offering, which was expected to close on or about June 26, 2026.
- Confirm the exact number of shares issued and the final aggregate proceeds after deducting transaction costs.
- Review the specific terms of the "HSR Satisfaction" and the timeline for stockholder approval required to lift the 9.99% and 19.99% beneficial ownership caps on the pre-funded warrants.
- Assess the impact of the new debt covenants and the $7.5 million judgment threshold on the Company's operational flexibility.
- Monitor the progress of the NVIDIA collaboration and the deployment of the 40,000 GPUs as the primary use of proceeds.